anti-Staphylococcus immunomodulator (Amoebics)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Nameanti-Staphylococcus immunomodulator (Amoebics)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsStaphylococcal Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmoebics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmoebics Ltd
Active IndicationsN/A
Inactive IndicationsStaphylococcal Infections

Other Information

ATC CodeN/A
Related LinksN/A